Webinar
Assessing mRNA and LNP Quality Attributes and Impurities
On-Demand
Detailed and sensitive characterization of ionizable lipids that make up lipid nanoparticles (LNP) and their related impurities is necessary to ensure the quality of mRNA therapies. Additionally, there are mRNA quality attributes such as 5’ capping that directly impact efficacy and safety.
Webinar
High-Quality Vaccine Development Powered by Quality Control Using Agilent Fragment Analyzer System
On-Demand
Speaking at the Vaccine Research & Development 2022, Kyle Luttgeharm, PhD, Product Manager from Agilent presented their talk on IVT RNA production and
accurate and precise mRNA analysis.
accurate and precise mRNA analysis.
Webinar
Rapid Screening and Scaled Manufacture of Immunogenic Virus-Like Particles
On-Demand
Speaking at the Vaccine Research & Development 2022, Jorge Armero Gimenez from Wageningen University & Research, presented their talk on Virus-Like Particles immunogenicity in human dendritic cells.
Webinar
Level Up Your LNP Making Skills With Nunchuck
On-Demand
The Problem
LNPs are a valuable tool in the repertoire of gene and vaccine delivery vectors but LNP development is a complex multi-step process.
LNPs are a valuable tool in the repertoire of gene and vaccine delivery vectors but LNP development is a complex multi-step process.
Webinar
Looking to the Future of Cell and Gene Therapies
On-Demand
This Technology Networks event features exclusive talks focused on the most recent and innovative developments in the world of cell and gene therapies. Our expert speakers will highlight the opportunities cell and gene therapies provide for the treatment of disease and injury, including how cell therapies are providing novel solutions for rare diseases such as Duchenne muscular dystrophy.
Webinar
Innovative Strategies for Therapeutic Antibody Development and Production
On-Demand
This exclusive Technology Networks webinar focuses on the most recent and innovative strategies for therapeutic antibody development and production. Your speaker, Professor Brockwell, will describe the development and use of a new assay to investigate important proteins in disease screening and the biopharmaceutical industry.
Advertisement